A combination of four genes (p16, ARF, MGMT, and GSTP1) has been proposed to detect prostate cancer with an estimated 87% sensitivity and 100% specificity (Hoque et al. 2005). This evidence concerns the gene GSTP1 and prostate carcinoma.